Example 15
Anti-CD3 FITC (Clone BW264/56, Miltenyi Biotec), anti-CD8-APC (SK1, BD Pharmingen), Dextramer-HPV E711-20-PE (Dext-HPV PE; HLA-A*0201; YMLDLQPETT, Immudex), Dextramer-HIV-1 P17 Gag 77-85-PE (Dext-HIV-PE; HLA-A*0201; SLYNTVATL, Immudex), anti-TCR-Vß3-FITC (JOVI-3, Ancell) were used. Cells were incubated with dextramer for 10 min at room temperature, then anti-CD3, -CD8, -Vß3 antibodies were added for 30 min at 4° C. Perforin and granzyme intracellular staining was performed with specific antibodies in PBS/0.5% BSA/0.1% NaN3 containing saponin (0.5%) at room temperature for 20 min. Stained cells were washed with PBS/0.5% BSA/0.1% NaN3 and analyzed using a FACSCalibur flow cytometer (Becton Dickinson).
US10018629B2. Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus (2018-07-10). INSTITUT PASTEUR [FR], INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) [FR], UNIVERSITE PARIS DIDEROT PARIS 7 [FR], ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS [FR]. Inventors: Marie-Lise Gougeon [FR], Manuelle Viguier [FR], Hervé Bachelez [FR], Nicolas Fazilleau [FR].